# Effect of Eszopiclone on Adherence to CPAP and Severity of Insomnia in Patients With COMISA

> **NCT06017921** · PHASE4 · UNKNOWN · sponsor: **University of Sao Paulo General Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Obstructive Sleep Apnea
- Insomnia

## Interventions

- **DRUG:** Eszopiclone 3 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06017921
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-24
- **Primary completion:** 2025-03-20
- **Final completion:** 2025-12-20
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06017921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06017921, "Effect of Eszopiclone on Adherence to CPAP and Severity of Insomnia in Patients With COMISA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06017921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*